Skip to content
PPepIndex

HGH Fragment 176-191

Metabolic

Also known as HGH Frag 176-191, Growth hormone fragment 176-191, Frag 176-191

Research focusFat loss & metabolic
1.3/ 5evidence coverage 38%
D

Evidence tier

Limited published literature

4 publications over 48 years · trials not yet curated

Researched since
1978
Publications
4
Mean purity
Vendors listing
0

No indexed vendor publishes certificate records for HGH Fragment 176-191 that this index could read yet, so no purity comparison is possible.

Score breakdown

The score has two halves: the research base — how long the compound has been studied and how much has been published — and the quality of the evidence the market produces for it, aggregated across every vendor that carries it: assayed purity, lot-to-lot consistency, readable third-party certificates and those vendors’ review record. It measures the evidence base, not the merits or safety of the substance.

Research evidence24.0 / 24

Studied since 1978 — 48 years of published research

How long the compound has been studied. Fifteen years or more of published literature earns full marks; a newer compound earns less.

Research volume1.1 / 14

4 publications indexed in PubMed

The volume of published literature located. Full marks at fifty or more publications.

Vendor purity0.0 / 22

No certificate records indexed yet — nothing recorded yet

Average assayed purity on the certificates published by vendors that carry this compound. Full marks at 99.5%+, nothing at 95% or below.

Lot-to-lot consistency0.0 / 12

No certificate records indexed yet — nothing recorded yet

How tightly assayed purity and labeled-versus-actual mass hold across different lots. Rewards reproducible manufacturing.

Testing transparency0.0 / 14

No vendor testing policy recorded yet — nothing recorded yet

Whether the vendors carrying this compound publish per-lot certificates anyone can read without an account.

Third-party testing0.0 / 14

No certificate records indexed yet — nothing recorded yet

Share of certificates issued by a recognised third-party testing lab rather than an unnamed or self-named one.

Total25.1 / 100

What is HGH Fragment 176-191?

A synthetic fragment corresponding to residues 176-191 of human growth hormone, studied in animal models for effects on lipid metabolism. The stabilised analogue AOD-9604 is tracked separately in this index.

Studied in published research for fat metabolism and weight loss.

Regulatory status

Labeled by vendors for laboratory research use only. Not approved as a medicine in the United States, United Kingdom, or European Union.

What the research examines

1 area

The areas of published research this compound appears in. These describe what the literature has studied — never a claim of benefit, effect or suitability for any use.

Published research

4 citations

PepIndex records the size and shape of the published research footprint only. It does not evaluate or summarise clinical significance, does not describe administration, and nothing here is a claim of safety or efficacy.

PepIndex describes what literature exists. We do not interpret it, assess clinical significance, or publish quantities, protocols or instructions for use.

Vendor comparison

Vendors are ranked for HGH Fragment 176-191specifically: the score folds in this compound’s price per milligram against the market median, alongside the same documentation and testing that drive the overall board — so a vendor that is cheap on HGH Fragment 176-191 outranks a pricier one of equal documentation, even if the pricier vendor sits higher overall. A vendor without a captured price for HGH Fragment 176-191 is judged on its overall basket price. Purity and deviation come from the certificate records indexed for each vendor.
VendorScore herePrice / mgCertificatesMean purityLabel deviationGet it

Certificate records

0 lot records

No certificate records are indexed. Either none are published, or those published could not be read without an account.

How to read a certificate of analysis